Inspired by Faith, We Serve and Celebrate Seniors


Central Baptist Village Blog

National Institutes of Health, drug industry and nonprofit organizations join forces

In exciting news for patients and caregivers, the National Institutes of Health (NIH), ten drug companies, and several nonprofit organizations, including the Alzheimer’s Association, have joined together in the Accelerating Medicines Partnership (AMP). AMP’s goal is to increase the number of new diagnostics and therapies for patients and reduce the time and cost of developing them. The first projects will focus on Alzheimer’s, type 2 diabetes, and the autoimmune diseases rheumatoid arthritis and lupus (systemic lupus erythematosus).

“Patients and their caregivers are relying on science to find better and faster ways to detect and treat disease and improve their quality of life,” said NIH Director Francis S. Collins, M.D., Ph.D. “Currently, we are investing a great deal of money and time in avenues with high failure rates, while patients and their families wait. All sectors of the biomedical enterprise agree that new approaches are sorely needed . . . it’s time to work together in new ways to increase our collective odds of success.”

You can read more about AMP here:

Leave a Reply

central baptist village

Welcoming Seniors
of All Faiths Since 1896

Central Baptist Village is a not-for-profit continuing care retirement community with more than a century of dedicated service in caring for older adults.

Why choose
Central Baptist Village?

Our team approach supports residents and their families through the transitions of aging. We offer on-site independent living, assisted living, memory support care, skilled nursing care and short-term rehabilitation. Residents enjoy enhanced independence and greater peace of mind knowing health care needs are based on a personalized plan and delivered within a community of friendship, faith, and family.

award-winning care

Central Baptist Village is fully focused on the safety of our community. For our complete COVID-19 response, please click here.